Sun Pharma up on getting boost in Taro war

The stock ended at Rs 1,468, up 1% from its previous close. The counter clocked volumes of  18,616 shares as compared to the two-week daily average traded volumes of 30,875 shares on the BSE.
_____________________________________-

(Updated at 1112hrs)

Sun Pharmaceuticals advances on getting boost in Taro battle.

The stock opened at Rs 1,453 and soared to a high of Rs 1,470. The scrip is now trading at Rs 1,466, up 1% from its previous close. The counter has clocked volumes of 5,446 shares as compared to the two-week daily average traded volumes of 30,875 shares on the BSE.

The company's attempts to acquire Taro Pharmaceuticals received a major boost with the Israeli company’s second-largest minority shareholder, Templeton Asset Management, asking its shareholders not to support the existing management and to vote against their decisions and to demand audited financial statements.